UMIN ID: UMIN000001116
Registered date:09/04/2008
JPLT2 protocol (CITA and ITEC regimen)for the pediatric liver tumor in Japan
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | hepatoblastoma hepatocellular carcinoma |
| Date of first enrollment | 2000/04/01 |
| Target sample size | 220 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Effect of tumor reduction Improvement of event-free and overall survivals Safety |
|---|---|
| Secondary Outcome | Pancytopenia Digestive organ dysfunction Late complications (cardiac dysfunction, growth disorder, hearing disorder) |
Key inclusion & exclusion criteria
| Age minimum | 1days-old |
|---|---|
| Age maximum | 15years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Note that, even if an intrahepatic tumor, the benign liver tumor, hepatocellular carcinoma, and metastatic liver tumors should be excluded. |
Related Information
| Primary Sponsor | Japanese Study Group for Pediatric Liver Tumors |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Foundation from Children's cancer assotiation of Japan. Mitsui Life Social Walfare Foundation.,Children's Cancer Association of Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Sho Kurihara |
| Address | 1-2-3,Kasumi,Minami-ku,Hiroshima Japan 734-8551 |
| Telephone | 082-257-5216 |
| kogura@hiroshima-u.ac.jp | |
| Affiliation | Hiroshima university hospital Pediatric Surgery |
| scientific contact | |
| Name | Hiyama Eiso |
| Address | 1-2-3,Kasumi,Minami-ku,Hiroshima Japan |
| Telephone | 082-257-5951 |
| eiso@hiroshima-u.ac.jp | |
| Affiliation | Hiroshima University Natural Science Center for Basic Research and Development |